Table 2.
Association of FDG uptake of lateral lymph node and ultrasonography-guided FNA results in patients with FDG positivity of lateral lymph node
| Patient no | Location of lateral LN | SUVmax of lateral LN | FNA result |
|---|---|---|---|
| 1 | Rt. II | 3.4 | Reactive |
| 2 | Lt. II | 5.3 | Metastasis |
| Lt. III | 16.0 | Metastasis | |
| 3 | Rt.IB | 4.7 | Metastasis |
| 4 | Lt.II | 3.5 | Reactive |
| Lt.III | 3.1 | Metastasis | |
| 5 | Rt.IB | 3.6 | Reactive |
| 6 | Rt.III | 7.0 | Reactive |
| 7 | Rt.II | 3.8 | Reactive |
| Lt.II | 3.2 | Reactive | |
| 8 | Lt.V | 12.7 | Reactive |
| 9 | Lt.III | 3.1 | Reactive |
| 10 | Rt.II | 6.8 | Metastasis |
| Lt.II | 4.0 | Metastasis | |
| 11 | Lt.II | 4.6 | Reactive |
| 12 | Rt.II | 9.2 | Metastasis |
| Rt.IV | 11.6 | Metastasis | |
| Rt.III | 2.8 | Metastasis | |
| 13 | Lt.II | 10.3 | Metastasis |
| Lt.III | 5.8 | Metastasis |
The classification of cervical lymph nodes from consensus statement on the terminology and classification of central neck dissection for thyroid cancer. 2009 The American Thyroid Association Surgery Working Group
FDG fluorodeoxyglucose, LN lymph node, FNA fine-needle aspiration, SUV standardized uptake value